MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03054cam a22004214a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
12678247 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20210304103918.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
020213s2002 dcua b 001 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2002018455 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
1582120358 |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(DNLM)101138202 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
EG-NcFUE |
| Transcribing agency |
EG-NcFUE |
| Modifying agency |
DLC |
| Description conventions |
rda |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
pcc |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RS200 |
| Item number |
.A45 2002 |
| 060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
QV 778 |
| Item number |
A427a 2002 |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Edition number |
21 |
| Classification number |
615.4 |
| Item number |
A.L.A |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Allen, Loyd V. |
| Relator term |
author |
| 245 14 - TITLE STATEMENT |
|---|
| Title |
The art, science, and technology of pharmaceutical compounding / |
| Statement of responsibility, etc |
Loyd V. Allen, Jr. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
Second edition |
| 264 #1 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Washington, D.C. : |
| Name of publisher, distributor, etc |
American Pharmaceutical Association, |
| Date of publication, distribution, etc |
[2002] |
| 264 #4 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
©2002. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xxvi, 493 pages : |
| Other physical details |
illustrations ; |
| Dimensions |
26 cm. |
| 336 ## - CONTENT TYPE |
|---|
| Source |
rdacontent |
| Content type term |
text |
| 337 ## - MEDIA TYPE |
|---|
| Source |
rdamedia |
| Media type term |
unmediated |
| 338 ## - CARRIER TYPE |
|---|
| Source |
rdacarrier |
| Carrier type term |
volume |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Sample FormulationsPreface to Second EditionPreface to First EditionIntroductionAbbreviations and Approximate Solubility DescriptorsChapter 1 Guidelines for Compounding PracticesChapter 2 Facilities, Equipment, and SuppliesChapter 3 Records and Record KeepingChapter 4 Stability of Compounded ProductsChapter 5 Pharmaceutical Compounding CalculationsChapter 6 Quality ControlChapter 7 Flavors, Sweeteners, and ColorsChapter 8 Preservation, Sterilization, and DepyrogenationChapter 9 Powders and GranulesChapter 10 CapsulesChapter 11 TabletsChapter 12 Lozenges/TrochesChapter 13 SuppositoriesChapter 14 SticksChapter 15 SolutionsChapter 16 SuspensionsChapter 17 EmulsionsChapter 18 Ointments, Creams, and PastesChapter 19 GelsChapter 20 Ophthalmic, Otic, and Nasal PreparationsChapter 21 Inhalation ProductsChapter 22 Parenteral PreparationsChapter 23 Biotechnology PreparationsChapter 24 Compounding for Special Populations and Special ProductsChapter 25 Veterinary Pharmaceutical CompoundingAppendix I Agents Withdrawn by FDA Because of Safety/Efficacy ConcernsAppendix II Specific Gravity ValuesAppendix III Sodium Chloride Equivalent Values of Selected AgentsAppendix IV Buffers and Buffer SolutionsAppendix V Viscosity-Increasing Agents for Aqueous Systems<br/> |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
Presents the information a pharmacy student needs to understand the purpose and processes of compounding in a logical and progressive format. This comprehensive reference provides practitioners with useful information on establishing, equipping, and operating a compounding facility. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drugs |
| General subdivision |
Dosage forms. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drug Compounding. |
| 856 41 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
Table of contents |
| Uniform Resource Identifier |
<a href="http://www.loc.gov/catdir/toc/mh031/2002018455.html">http://www.loc.gov/catdir/toc/mh031/2002018455.html</a> |
| 856 42 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
Publisher description |
| Uniform Resource Identifier |
<a href="http://www.loc.gov/catdir/description/mh031/2002018455.html">http://www.loc.gov/catdir/description/mh031/2002018455.html</a> |
| 856 42 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
Book review (E-STREAMS) |
| Uniform Resource Identifier |
<a href="http://www.e-streams.com/es0611/es0611_2878.html">http://www.e-streams.com/es0611/es0611_2878.html</a> |
| 906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) |
|---|
| a |
7 |
| b |
cbc |
| c |
orignew |
| d |
1 |
| e |
ecip |
| f |
20 |
| g |
y-gencatlg |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Books |